Cambridge Investment Research Advisors’s Olin OLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $896K | Sell |
45,226
-479
| -1% | -$12.5K | ﹤0.01% | 2413 |
|
|
2026
Q1 | $1.36M | Buy |
45,705
+9,792
| +27% | +$239K | ﹤0.01% | 1911 |
|
|
2025
Q4 | $748K | Buy |
35,913
+21,875
| +156% | +$472K | ﹤0.01% | 2357 |
|
|
2025
Q3 | $351K | Buy |
14,038
+2,302
| +20% | +$51.1K | ﹤0.01% | 2980 |
|
|
2025
Q2 | $236K | Sell |
11,736
-5,963
| -34% | -$124K | ﹤0.01% | 3190 |
|
|
2025
Q1 | $429K | Sell |
17,699
-9,378
| -35% | -$264K | ﹤0.01% | 2578 |
|
|
2024
Q4 | $915K | Sell |
27,077
-12,324
| -31% | -$515K | ﹤0.01% | 1943 |
|
|
2024
Q3 | $1.89M | Sell |
39,401
-1,659
| -4% | -$73.8K | 0.01% | 1394 |
|
|
2024
Q2 | $1.94M | Buy |
41,060
+152
| +0.4% | +$8.13K | 0.01% | 1296 |
|
|
2024
Q1 | $2.4M | Sell |
40,908
-995
| -2% | -$53.4K | 0.01% | 1152 |
|
|
2023
Q4 | $2.26M | Buy |
41,903
+148
| +0.4% | +$7.09K | 0.01% | 1126 |
|
|
2023
Q3 | $2.09M | Sell |
41,755
-6,574
| -14% | -$355K | 0.01% | 1109 |
|
|
2023
Q2 | $2.48M | Sell |
48,329
-279
| -0.6% | -$14.8K | 0.01% | 1043 |
|
|
2023
Q1 | $2.7M | Sell |
48,608
-5,558
| -10% | -$318K | 0.01% | 963 |
|
|
2022
Q4 | $2.87M | Buy |
54,166
+6
| +0% | +$318 | 0.01% | 885 |
|
|
2022
Q3 | $2.32M | Buy |
54,160
+805
| +2% | +$40.8K | 0.01% | 956 |
|
|
2022
Q2 | $2.47M | Buy |
53,355
+38,726
| +265% | +$2.24M | 0.01% | 944 |
|
|
2022
Q1 | $765K | Sell |
14,629
-98
| -0.7% | -$5.01K | ﹤0.01% | 1778 |
|
|
2021
Q4 | $847K | Buy |
14,727
+1,997
| +16% | +$112K | ﹤0.01% | 1697 |
|
|
2021
Q3 | $614K | Sell |
12,730
-4,058
| -24% | -$189K | ﹤0.01% | 1888 |
|
|
2021
Q2 | $777K | Buy |
16,788
+4,930
| +42% | +$222K | ﹤0.01% | 1723 |
|
|
2021
Q1 | $450K | Sell |
11,858
-2,449
| -17% | -$74.2K | ﹤0.01% | 1974 |
|
|
2020
Q4 | $351K | Sell |
14,307
-445
| -3% | -$9.05K | ﹤0.01% | 2016 |
|
|
2020
Q3 | $183K | Buy |
+14,752
| New | +$171K | ﹤0.01% | 2270 |
|
|
2019
Q4 | – | Sell |
-10,926
| Closed | -$205K | – | 2454 |
|
|
2019
Q3 | $205K | Sell |
10,926
-3,180
| -23% | -$59.9K | ﹤0.01% | 2102 |
|
|
2019
Q2 | $309K | Buy |
14,106
+549
| +4% | +$12.2K | ﹤0.01% | 1733 |
|
|
2019
Q1 | $314K | Buy |
+13,557
| New | +$324K | ﹤0.01% | 1775 |
|
|
2018
Q3 | – | Sell |
-8,138
| Closed | -$234K | – | 2286 |
|
|
2018
Q2 | $234K | Buy |
8,138
+1,313
| +19% | +$40.8K | ﹤0.01% | 1901 |
|
|
2018
Q1 | $207K | Buy |
6,825
+1,187
| +21% | +$40.4K | ﹤0.01% | 1943 |
|
|
2017
Q4 | $201K | Buy |
+5,638
| New | +$200K | ﹤0.01% | 1928 |
|
|
2017
Q2 | – | Sell |
-6,338
| Closed | -$208K | – | 1968 |
|
|
2017
Q1 | $208K | Sell |
6,338
-17,703
| -74% | -$531K | ﹤0.01% | 1591 |
|
|
2016
Q4 | $616K | Buy |
24,041
+492
| +2% | +$11.7K | 0.01% | 915 |
|
|
2016
Q3 | $483K | Buy |
23,549
+13,360
| +131% | +$288K | 0.01% | 1052 |
|
|
2016
Q2 | $253K | Buy |
+10,189
| New | +$220K | 0.01% | 1256 |
|
Other funds holding OLN
Cambridge Investment Research Advisors's OLN Position: Q2 2026 in Review
Cambridge Investment Research Advisors reduced its Olin (OLN) stake by 1% in Q2 2026, selling an estimated $12.5K and leaving 45,226 shares worth $896K. The position accounts for ﹤0.01% of the portfolio, ranked #2413.
Cambridge Investment Research Advisors first reported a position in OLN in Q2 2016 and has held it in 34 quarters since. The position peaked at $2.87M in Q4 2022. 414 funds tracked by Wall St. Rank hold OLN as of Q2 2026.
- Cambridge Investment Research Advisors held 45,226 shares of Olin worth $896K as of Q2 2026.
- Cambridge Investment Research Advisors sold 479 Olin shares in Q2 2026, an estimated $12.5K.
- Olin made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2413 holding.
- Cambridge Investment Research Advisors first reported a position in Olin in Q2 2016 and has held it in 34 quarters since.
- Cambridge Investment Research Advisors's Olin position peaked at $2.87M in Q4 2022.
- 414 funds tracked by Wall St. Rank held Olin as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.